In view of the COVID-19 pandemic, the Central Drugs Standard Control Organisation (CDSCO) has allowed import of drugs with a less than 60 per cent residual shelf life on the condition that the importers shall have to give an undertaking that the drug would be utilized or consumed before the expiry date.
from IndiaTV India: Google News Feed https://ift.tt/2ytqjtb